Waters Parkerson & CO. LLC Sells 7,720 Shares of The Procter & Gamble Company (NYSE:PG)

Waters Parkerson & CO. LLC lowered its holdings in shares of The Procter & Gamble Company (NYSE:PG) by 3.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 244,662 shares of the company’s stock after selling 7,720 shares during the quarter. Procter & Gamble accounts for about 2.1% of Waters Parkerson & CO. LLC’s portfolio, making the stock its 15th largest position. Waters Parkerson & CO. LLC’s holdings in Procter & Gamble were worth $40,350,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Fairway Wealth LLC purchased a new position in Procter & Gamble in the second quarter worth about $29,000. Transcendent Capital Group LLC bought a new position in shares of Procter & Gamble during the 4th quarter valued at approximately $31,000. Ruedi Wealth Management Inc. boosted its stake in Procter & Gamble by 64.7% during the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after buying an additional 77 shares during the period. POM Investment Strategies LLC bought a new position in Procter & Gamble during the second quarter valued at $34,000. Finally, Vima LLC purchased a new stake in shares of Procter & Gamble in the fourth quarter valued at $35,000. 65.77% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

PG has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Procter & Gamble from $171.00 to $176.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Evercore ISI increased their price target on Procter & Gamble from $177.00 to $183.00 and gave the stock an “outperform” rating in a report on Thursday, July 18th. Wolfe Research upgraded Procter & Gamble to a “strong-buy” rating in a research note on Friday, August 23rd. Citigroup lifted their price objective on shares of Procter & Gamble from $177.00 to $190.00 and gave the company a “buy” rating in a report on Wednesday, July 10th. Finally, Dbs Bank lowered Procter & Gamble from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 1st. Seven equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $176.16.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, CFO Andre Schulten sold 13,041 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the sale, the chief financial officer now owns 37,208 shares of the company’s stock, valued at approximately $6,325,360. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In related news, CEO Ma. Fatima Francisco sold 96,000 shares of Procter & Gamble stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $170.00, for a total transaction of $16,320,000.00. Following the completion of the sale, the chief executive officer now owns 13,721 shares of the company’s stock, valued at $2,332,570. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Andre Schulten sold 13,041 shares of the stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the transaction, the chief financial officer now owns 37,208 shares in the company, valued at approximately $6,325,360. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 375,553 shares of company stock worth $63,829,141. Insiders own 0.17% of the company’s stock.

Procter & Gamble Stock Down 1.4 %

Shares of Procter & Gamble stock opened at $171.54 on Friday. The Procter & Gamble Company has a 52-week low of $141.45 and a 52-week high of $177.94. The firm’s 50 day moving average price is $170.06 and its 200-day moving average price is $165.59. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51. The company has a market cap of $404.86 billion, a P/E ratio of 28.03, a PEG ratio of 3.76 and a beta of 0.41.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.37 by $0.03. The business had revenue of $20.53 billion for the quarter, compared to the consensus estimate of $20.69 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The business’s quarterly revenue was down .1% on a year-over-year basis. During the same period in the prior year, the firm posted $1.37 earnings per share. On average, sell-side analysts predict that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were issued a $1.0065 dividend. This represents a $4.03 annualized dividend and a yield of 2.35%. The ex-dividend date of this dividend was Friday, July 19th. Procter & Gamble’s dividend payout ratio is presently 65.85%.

Procter & Gamble Company Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.